Kinetiq Therapeutics LLC
Fort Worth, TX
- UEI
- DNDJDBCC4FT9
- CAGE
- 9J6L3
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Sole Proprietorship
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 3420 Darcy St, Fort Worth, TX 76107, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Evaluating a novel enzymatic modality for the treatment of fanconi anemia - project summary fanconi anemia is an… | National Heart Lung and Blood Institute | $306,870 | |
| Preclinical efficacy of subcutaneous enzyme therapy for lysosomal fabry disease - project summary fabry disease is a… | National Center for Advancing Translational Sciences | $295,923 |
Quick answers
What is Kinetiq Therapeutics LLC's UEI?
Kinetiq Therapeutics LLC's Unique Entity ID (UEI) in SAM.gov is DNDJDBCC4FT9.
What is Kinetiq Therapeutics LLC's CAGE code?
Kinetiq Therapeutics LLC's CAGE code is 9J6L3.
What is Kinetiq Therapeutics LLC's primary NAICS code?
Kinetiq Therapeutics LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Kinetiq Therapeutics LLC located?
Kinetiq Therapeutics LLC's physical address in SAM.gov is 3420 Darcy St, Fort Worth, TX 76107, USA.
Is Kinetiq Therapeutics LLC registered in SAM.gov?
Yes. Kinetiq Therapeutics LLC's SAM.gov registration is active through January 22, 2027.
What is Kinetiq Therapeutics LLC's most recent federal award?
Kinetiq Therapeutics LLC's most recent federal grant award is Evaluating a novel enzymatic modality for the treatment of fanconi anemia - project summary fanconi anemia is an… (R43HL176246), from National Heart Lung and Blood Institute, on August 20, 2024.
On GovTribe
See Kinetiq Therapeutics LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors